TORRENT PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,601 INR | +3.16% |
|
-4.80% | +12.86% |
Presenter SpeechChintan Trivedi (Executives)Good morning to all. I am Chintan Trivedi, Company...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Sector
Pharmaceuticals
Calendar
2024-05-23
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
2,601
INR
Average target price
2,729
INR
Spread / Average Target
+4.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.86% | 10.54B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- TORNTPHARM Stock
- News Torrent Pharmaceuticals Limited
- Transcript : Torrent Pharmaceuticals Limited - Shareholder/Analyst Call
